LEAP THERAPEUTICS, INC. (LPTX) Insider Trading -- Recent Executive & Director Transactions

7 insiders reported 11 Form 4 transactions for LEAP THERAPEUTICS, INC. (LPTX) over the past 18 months (most recent 2025-04-01). Recent activity: LAWLOR AUGUSTINE (Chief Operating Officer) Buy 22,500 shares, O'Mahony John Mark (Chief Manufacturing Officer) Buy 22,500 shares, Baum Jason (Chief Scientific Officer) Buy 22,500 shares, Baum Jason (Chief Scientific Officer) Sell 6,604 shares, Mirabelli Christopher (Chairman of the Board) Buy 22,500 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2025-04-01LAWLOR AUGUSTINEChief Operating OfficerBuy22,500$0
2025-04-01O'Mahony John MarkChief Manufacturing OfficerBuy22,500$0
2025-04-01Baum JasonChief Scientific OfficerBuy22,500$0
2025-04-01Baum JasonChief Scientific OfficerSell6,604$2,113
2025-04-01Mirabelli ChristopherChairman of the BoardBuy22,500$0
2025-04-01Mirabelli ChristopherChairman of the BoardSell6,672$2,135
2025-04-01Sirard CynthiaChief Medical OfficerBuy22,500$0
2025-04-01Granfield ChristineVP, Head of Reg Affairs/QualBuy22,500$0
2025-04-01Granfield ChristineVP, Head of Reg Affairs/QualSell6,604$2,113
2025-04-01ONSI DOUGLAS ECEO,CFO,Pres.,GC,Treas.&Sec.Buy32,500$0
2025-04-01LAWLOR AUGUSTINEChief Operating OfficerSell7,797$2,495

Source: SEC Form 4 filings · as of 2025-04-01